Clinical Trial Update: Can Platelets/Lymphocytes Rate Be New Serological Index for Prognosis of Coronary Heart Disease Complicated With Impaired Glucose Tolerance: Basic Principles and Experimental Design

View source ↗

Summary

A clinical trial update outlining the basic principles and experimental design to evaluate whether the platelets/lymphocytes rate can serve as a prognostic sero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease with Impaired Glucose Tolerance

Snippet

Sponsor: Affiliated Hospital of Hebei University | Conditions: Coronary Heart Disease Complicated With Impaired Glucose Tolerance | Status: COMPLETED